Company News 

AstraZeneca vaxxed to the max

AstraZeneca vaxxed to the max

The fight against Covid-19 stepped up a gear, after AstraZeneca (AZN) announced that it has reached initial agreements which would lead to the widespread distribution of at least 400m doses of the vaccine being developed by scientists at Oxford University.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now